ACUT Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (23 bal. 2024 @ 16:30):

AccuStem Sciences, Inc. operates as a life sciences company focusing on improving outcomes for patients with cancer. It develops StemPrintER technology, a multi-gene prognostic assay to predict the risk of recurrence of Endocrine receptor-positive /HER2- breast cancer; and Spare, a derivative of StemPrintER that combines StemPrintER with two clinical markers...

Stats
Dzisiejszy wolumen	75.00
Średni wolumen	2 867.00
Kapitalizacja rynkowa	3.13M
EPS	$-0.0528 ( 2023-09-29 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2022-12-30	Cerrone Gabriele M	Buy	5 000	Common Stock
2022-12-02	Cerrone Gabriele M	Buy	3 729	Common Stock
2022-11-18	Cerrone Gabriele M	Buy	24 500	Common Stock
2022-08-01	Cerrone Gabriele M	Buy	10 000	Common Stock
2022-06-08	Cerrone Gabriele M	Buy	20 000	Common Stock

INSIDER POWER
100.00
Last 6 transactions
Buy: 67 410 \| Sell: 0

Accustem Sciences Inc. Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Accustem Sciences Inc. Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$-3 630.00 (0.00 %)
EPS:	$-0.180

FY	2023
Przychody:	$0
Zysk brutto:	$-3 630.00 (0.00 %)
EPS:	$-0.180

FY	2022
Przychody:	$0
Zysk brutto:	$-3 321.00 (0.00 %)
EPS:	$-0.340

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.0670

Financial Reports:

No articles found.

Accustem Sciences Inc.